Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone and vitamin B1, B6, and B12 in patients with Post-COVID-19-Syndrome (PC19S)
DRKS00029617Phase 3Completed
- Sponsor
- University Hospital Würzburg
- Start
- Nov 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of prednisolone, thiamine, pyridoxine and cyanocobalamin in post-COVID syndrome (4 arms), sponsored by University Hospital Würzburg. Started Nov 2022; status: completed.
02
Drugs
prednisolonethiaminepyridoxinecyanocobalamin
03
Conditions
post-COVID syndrome
Beyond the preview
Go deeper on DRKS00029617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00029617.